trending Market Intelligence /marketintelligence/en/news-insights/trending/5n-9Lk_GSb1Cyq05wKwJOQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Arch Therapeutics to raise $2.5M via registered direct offering of units

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Arch Therapeutics to raise $2.5M via registered direct offering of units

Arch Therapeutics Inc. plans to raise about $2.5 million in gross proceeds via a registered direct offering of units.

The Framingham, Mass.-based biotechnology plans to sell 14,285,714 units at 17.5 cents apiece. Each unit consists of one common share and one warrant to purchase a common share of the company. The warrants come with an exercise price of 22 cents and are valid for five years from the issuance date.

The offering is expected to close on or about Oct. 18.

The company plans to use the net proceeds from the offering for working capital and general corporate purposes.

H.C. Wainwright & Co. is the exclusive placement agent for the offering.